| Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies |
21 |
| Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study |
12 |
| Esophageal foreign bodies in adults: systematic review of the literature |
11 |
| Changes in inflammatory bowel disease subtype during follow-up and over time in 302 patients |
10 |
| Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study |
10 |
| Application of convolutional neural networks for evaluating Helicobacter pylori infection status on the basis of endoscopic images |
10 |
| Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials |
10 |
| Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population |
9 |
| Long-term evolution of direct healthcare costs for inflammatory bowel diseases: a population-based study (2006-2015) |
8 |
| Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD) |
8 |
| MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5 |
8 |
| Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology |
8 |
| Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia |
8 |
| Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis |
8 |
| Serum interleukin-6 level is associated with response to infliximab in ulcerative colitis |
8 |
| Nutritional status and nutritional risk in patients with neuroendocrine tumors |
8 |
| Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study |
8 |
| High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO) |
8 |
| Comparison of 20-gauge Procore (R) and 22-gauge Acquire (R) needles for EUS-FNB of solid pancreatic masses: an observational study |
8 |
| Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE) |
7 |
| Quantification of parenchymal calcifications in chronic pancreatitis: relation to atrophy, ductal changes, fibrosis and clinical parameters |
7 |
| Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study |
7 |
| Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer |
7 |
| Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study |
7 |
| Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors |
7 |
| Clostridium butyricum protects the epithelial barrier by maintaining tight junction protein expression and regulating microflora in a murine model of dextran sodium sulfate-induced colitis |
7 |
| Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy |
7 |
| High and low body mass index may predict severe disease course in children with inflammatory bowel disease |
7 |
| Evaluation of risk factors for recurrent primary common bile duct stone in patients with cholecystectomy |
7 |
| Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels |
7 |
| Early fecal microbiota composition in children who later develop celiac disease and associated autoimmunity |
7 |
| Outcome of peroral endoscopic myotomy (POEM) in treatment-naive patients. A systematic review |
6 |
| The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis |
6 |
| Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives |
6 |
| Optical classification of neoplastic colorectal polyps - a computer-assisted approach (the COACH study) |
6 |
| TRIM2 is a novel promoter of human colorectal cancer |
6 |
| Success and safety of high infliximab trough levels in inflammatory bowel disease |
6 |
| Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study |
6 |
| Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility |
6 |
| Microscopic colitis in Denmark and Sweden: incidence, putative risk factors, histological assessment and endoscopic activity |
6 |
| Anemia following Roux-en-Y gastric bypass for morbid obesity; a 5-year follow-up study |
6 |
| Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study |
6 |
| Validating microscopic colitis (MC) in Swedish pathology registers |
6 |
| The impacts of an inflammatory bowel disease nurse specialist on the quality of care and costs in Finland |
6 |
| EUS-guided reverse bevel fine-needle biopsy sampling and open tip fine-needle aspiration in solid pancreatic lesions - a prospective, comparative study |
6 |
| Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma |
6 |
| The role of EUS-guided fine needle aspiration in autoimmune pancreatitis: a single center prospective study |
6 |
| Antibiotics exposure and risk of inflammatory bowel disease: a systematic review |
5 |
| Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study |
5 |
| Diagnostic yield is not influenced by the timing of screening endoscopy: morning versus afternoon |
5 |
